17 Feb 2021 13:23
PT Kimia Farma (Persero) Tbk (KAEF) is building a drug raw material (BBO) production facility in Cikarang, Bekasi, West Java, to suppress imports of medicinal raw materials.
Kimia Farma builds production facility to suppress imports
13 Jan 2021 08:01
PT Kimia Farma Tbk (KAEF) and PT Kilang Pertamina Internasional (KPI) will develop a paracetamol factory with an investment value of US$40 million-50 million.
Kimia Farma and Pertamina subsidiary to establish paracetamol factory
08 Jan 2021 13:45
PT Kilang Pertamina Internasional (KPI), a subsidiary of PT Pertamina (Persero) and PT Kimia Farma Tbk (KAEF) will build a paracetamol pharmaceutical factory with a capacity of 3,800 tons per annum (TPA)
Pertamina and Kimia Farma to build a paracetamol factory
05 Jan 2021 09:38
PT Kimia Farma Apotek, a subsidiary of PT Kimia Farma Tbk (KAEF), announces plans to deploy Cloud Advertising Solutions developed by PT Digital Mediatama Maxima Tbk (DMMX)
Kimia Farma Apotek announces partnership with DMMX24 Aug 2020 08:29
G42 Healthcare Al Holding Rsc LTd, a pharmaceutical company from the United Arab Emirates (UAE) has signed an agreement to work with PT Indofarma (Persero) and PT Kimia Farma (Persero) Tbk (KAEF)
Two SOEs will work together with an UAE company to handle COVID-19
22 Jul 2020 12:26
The House of Representatives' Commission VI will recommend that state-owned pharmaceutical firm PT Kimia Farma (Persero) Tbk (KAEF) be given state equity capital to reduce ingredient import.
House of Representatives to recommend state equity capital for Kimia Farma
05 Jun 2020 12:08
PT Indofarma (Persero) Tbk (INAF), a pharmaceutical company owned by the Indonesian government, estimates that its sales during the first quarter (Q1) 2020 will decline by around 25%, unlike other pharmaceutical companies that gained momentum during the COVID-19 pandemic in Indonesia.
Indofarma's sales decline by 25% YoY in Q1 2020
20 May 2020 14:31
Pemeringkat Efek Indonesia (Pefindo) revised the outlook for the "idAA-" rating of PT Kimia Farma (Persero) Tbk (KAEF) to negative, due to high financial leverage and weak cash flow protection measures.
Pefindo downgrades Kimia Farma's outlook22 Apr 2020 16:30
PT Kimia Farma Tbk (KAEF) decided to cut this year's capital expenditure budget to Rp 547 billion.
Kimia Farma cuts 2020 capex to Rp 547 billion27 Mar 2020 12:01
PT Kimia Farma (Persero) Tbk (KAEF) recorded a loss of Rp 12.72 billion in 2019. In 2018, the company managed to record Rp 491.57 billion in net profit.
Kimia Farma lost Rp 12.72 billion in 2019